Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Julia L. Szeto"'
Autor:
Megha Sarvothama, Sushma Yechan-Gunja, Julia L. Szeto, Scott E. James, Sylvia M. Stull, Joshua R. Veatch, Matthew Fitzgibbon, Brenda Jesernig, Shivani Srivastava, Stanley R. Riddell, Naina Singhi
Publikováno v:
The Journal of Clinical Investigation
Therapeutic vaccines that augment T cell responses to tumor antigens have been limited by poor potency in clinical trials. In contrast, the transfer of T cells modified with foreign transgenes frequently induces potent endogenous T cell responses to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8a23a211fdcab33fd10795dcf99c957
http://europepmc.org/articles/PMC8363286
http://europepmc.org/articles/PMC8363286
Autor:
Joshua R. Veatch, Sylvia M. Lee, Carolyn Shasha, Naina Singhi, Julia L. Szeto, Ata S. Moshiri, Teresa S. Kim, Kimberly Smythe, Paul Kong, Matthew Fitzgibbon, Brenda Jesernig, Shailender Bhatia, Scott S. Tykodi, Evan T. Hall, David R. Byrd, John A. Thompson, Venu G. Pillarisetty, Thomas Duhen, A. McGarry Houghton, Evan Newell, Raphael Gottardo, Stanley R. Riddell
Publikováno v:
Cancer Cell
CD4(+) T cells that recognize tumor antigens are required for immune checkpoint inhibitor efficacy in murine models but their contributions in human cancer are unclear. We used single cell RNA sequencing and T cell receptor sequences to identify sign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc5650c9554cdaafbbe88b1943e35931
https://doi.org/10.1016/j.ccell.2022.03.006
https://doi.org/10.1016/j.ccell.2022.03.006